Can increased doses of Super Avana affect respiratory function or lead to breathing difficulties?

Ronymeran

Member
Feb 10, 2023
82
0
6
Super Avana is a medication that combines two active ingredients: avanafil and dapoxetine. Avanafil is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction (ED), while dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used to treat premature ejaculation (PE).

While respiratory side effects such as breathing difficulties are not commonly associated with avanafil or dapoxetine, it's essential to consider the potential impact of higher doses of Super Avana on respiratory function. Here are some factors to consider:

  1. Avanafil (PDE5 Inhibitor):
    • Avanafil, like other PDE5 inhibitors, primarily affects blood flow by relaxing smooth muscle tissue in blood vessels, particularly in the penis. While avanafil's primary mechanism of action is not related to respiratory function, it can cause mild systemic vasodilation, which may lead to transient changes in blood pressure.
    • While not typical, PDE5 inhibitors like avanafil have been associated with rare cases of non-arteritic anterior ischemic optic neuropathy (NAION), which involves sudden vision loss due to decreased blood flow to the optic nerve. While this is a rare side effect, it's important to consider potential effects on blood flow and vascular function throughout the body.
  2. Dapoxetine (SSRI):
    • Dapoxetine is primarily used to treat premature ejaculation by modulating serotonin levels in the brain. SSRIs like dapoxetine can affect various neurotransmitter systems, but they are not typically associated with respiratory side effects.
    • However, SSRIs may have some potential side effects such as dizziness, headache, or gastrointestinal disturbances, which could indirectly affect respiratory function if they cause symptoms such as nausea or lightheadedness.
  3. Individual variability:
    • Individual responses to medications can vary, and some individuals may be more sensitive to the effects of Super Avana on respiratory function than others. Factors such as underlying respiratory conditions, concurrent medication use, and overall health status can influence the likelihood and severity of respiratory side effects.